The Basopran brand, founded in 2010 (Denmark), from 307 sister brands and 2214 competing brands. The Basopran brand is owned by NOVO-NORDISK A/S, a company listed in Francfort. Basopran belongs to the Biotechnology business sector.

Basopran is a brand of NOVO-NORDISK A/S (NOVA) Share price

International deposit : 2010 Business sector Biotechnology

Share price and profitability of the share NOVO-NORDISK A/S (Basopran)

Buy NOVO-NORDISK A/S share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 116.50

Portfolio valuation
NOVO-NORDISK A/S (Basopran) over 5 years* EUR 634.22

Stock market history NOVO-NORDISK A/S (Basopran)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
NOVO-NORDISK A/S

INVERSAGO
INVERSAGO
Corvidia
Corvidia
Calibrium
Calibrium
MB2
MB2
ZIYLO
ZIYLO
Novo-Nordisk
Novo-Nordisk
See more brands of NOVO-NORDISK A/S

Rival brands
Basopran

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
ZEVRA THERAPEUTICS
ZEVRA THERAPEUTICS
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS